Serum insulin-like growth factor-1 as a potential prognostic biomarker for heart failure with reduced ejection fraction: a meta-analysis
Our meta-analysis has provided evidence suggesting a substantial correlation between reduced levels of IGF-1 and the occurrence of HF. Further prospective studies are necessary to ascertain the use of IGF-1 as a reliable biomarker for diagnosing HF, especially for HFrEF. But the diagnosis of HFpEF should be cautious.
Authors
- Mengqi Chen (ORCID: https://orcid.org/0000-0001-9728-8511)
- Fangyu Li (ORCID: https://orcid.org/0000-0003-2340-3622)
- Xin Tian (ORCID: https://orcid.org/0000-0003-1896-2462)
- Wen Wang (ORCID: https://orcid.org/0000-0002-3709-021X)
- Tingting Liu (ORCID: https://orcid.org/0000-0001-8008-4723)
- Zixin Zhu
- Fangling Sun (ORCID: https://orcid.org/0009-0002-2455-2750)
- Wenrong Zheng
- Yihuan Fei
Institutions
- Capital Medical University (CN)
- Hebei University of Science and Technology (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Chinese Institute for Brain Research (CN)
- National Clinical Research (US)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-09-17
- DOI
- https://doi.org/10.3389/fcvm.2024.1415238
- Citations
- 3
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 1.21
Funders
- National Natural Science Foundation of China